The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency
2017 marks the 11th year of the successful partnership between the CHEST Foundation and Alpha–1 Foundation in sponsoring a 1-year clinical research grant in alpha–1 antitrypsin (AAT) deficiency. The Alpha–1 Foundation is committed to finding a cure for alpha–1 antitrypsin (AAT) deficiency and to improving the lives of people affected by alpha–1 worldwide. Its grants and awards programs fund a broad range of research that leads to improvements in the health and quality of life of people living with AAT.
Deadline: Mar. 31, 2017
• CHEST membership at time of application. • Although applicants may be at later career stages, special consideration will be given to those within 5 years of completing an advanced training program. o Or equivalent experience. • The performance site must have a federal-wide assurance with the NIH for the protection of human subjects; not-for-profit organizations and institutions are eligible to apply.